A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum

[1]  M. Kuro-o,et al.  Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross‐sectional pilot study , 2018, Nephrology.

[2]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[3]  T. Hewitson,et al.  Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation , 2017, Front. Pharmacol..

[4]  T. Knöpfel,et al.  Acute Adaption to Oral or Intravenous Phosphate Requires Parathyroid Hormone. , 2017, Journal of the American Society of Nephrology : JASN.

[5]  P. Scherer,et al.  Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression. , 2017, Kidney international.

[6]  G. Navis,et al.  Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  Edward R. Smith,et al.  Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Edward R. Smith,et al.  Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-α. , 2016, Atherosclerosis.

[9]  A. Pasch.  Novel assessments of systemic calcification propensity , 2016, Current opinion in nephrology and hypertension.

[10]  Joshua D. Hutcheson,et al.  Genesis and growth of extracellular vesicle-derived microcalcification in atherosclerotic plaques , 2015, Nature materials.

[11]  E. Smith.  The Isolation and Quantitation of Fetuin-A-Containing Calciprotein Particles from Biological Fluids. , 2016, Methods in molecular biology.

[12]  M. Derwall.  Combining Near Infrared Fluorescent Imaging for Calcification and Inflammation in Vascular Tissue Samples Ex Vivo. , 2016, Methods in molecular biology.

[13]  T. Hewitson,et al.  Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology , 2015, Front. Immunol..

[14]  M. Razzaque,et al.  Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity. , 2015, BoneKEy reports.

[15]  A. Cheung,et al.  Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. , 2015, Journal of the American Society of Nephrology : JASN.

[16]  Edward R. Smith,et al.  The role of fetuin-A in mineral trafficking and deposition. , 2015, BoneKEy reports.

[17]  M. Mayr,et al.  Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. , 2015, Circulation research.

[18]  P. Midgley,et al.  An Endogenous Nanomineral Chaperones Luminal Antigen and Peptidoglycan to Intestinal Immune Cells , 2015, Nature nanotechnology.

[19]  T. Hewitson,et al.  Relative abundance of fetuin‐ A in peritoneal dialysis effluent and its association with in situ formation of calciprotein particles: An observational pilot study , 2015, Nephrology.

[20]  Jan Svoboda,et al.  Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer , 2015, Journal of extracellular vesicles.

[21]  J. Ix,et al.  Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study. , 2014, The American journal of clinical nutrition.

[22]  Edward R. Smith,et al.  The use of fibroblast growth factor 23 testing in patients with kidney disease. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[23]  H. Hulter,et al.  The human response to acute enteral and parenteral phosphate loads. , 2014, Journal of the American Society of Nephrology : JASN.

[24]  J. Ferreira,et al.  Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models , 2014, BMC Nephrology.

[25]  L. Tomlinson,et al.  Serum calcification propensity predicts all-cause mortality in predialysis CKD. , 2014, Journal of the American Society of Nephrology : JASN.

[26]  M. Kuro-o.  Calciprotein particle (CPP): a true culprit of phosphorus woes? , 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[27]  M. Kuro-o.  A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease , 2013, Kidney international supplements.

[28]  Keith C. Norris,et al.  No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. , 2013, Kidney international.

[29]  Edward R. Smith,et al.  Fetuin‐A‐containing calciprotein particle levels can be reduced by dialysis, sodium thiosulphate and plasma exchange. Potential therapeutic implications for calciphylaxis? , 2013, Nephrology.

[30]  J. Carrero,et al.  Use of phosphate-binding agents is associated with a lower risk of mortality. , 2013, Kidney international.

[31]  Z. Massy,et al.  Effects of sevelamer treatment on cardiovascular abnormalities in mice with chronic renal failure. , 2013, Kidney international.

[32]  Elena Aikawa,et al.  Macrophage-Derived Matrix Vesicles: An Alternative Novel Mechanism for Microcalcification in Atherosclerotic Plaques , 2013, Circulation research.

[33]  Edward R. Smith,et al.  Fetuin-A-Containing Calciprotein Particles Reduce Mineral Stress in the Macrophage , 2013, PloS one.

[34]  Edward R. Smith,et al.  Serum fetuin‐A concentration and fetuin‐A‐containing calciprotein particles in patients with chronic inflammatory disease and renal failure , 2013, Nephrology.

[35]  C. Hillery,et al.  Calcium‐phosphate microprecipitates mimic microparticles when examined with flow cytometry , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[36]  R. Shroff.  Phosphate is a vascular toxin , 2013, Pediatric Nephrology.

[37]  J. Floege,et al.  Nanoparticle-based test measures overall propensity for calcification in serum. , 2012, Journal of the American Society of Nephrology : JASN.

[38]  S. Gordon,et al.  Clearance of Fetuin-A–Containing Calciprotein Particles Is Mediated by Scavenger Receptor-A , 2012, Circulation research.

[39]  H. Morgenstern,et al.  Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  Willem Stoorvogel,et al.  Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by high-resolution flow cytometry , 2012, Nature Protocols.

[41]  Edward R. Smith,et al.  Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  Z. Massy,et al.  Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[43]  Jau-Song Yu,et al.  Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandem mass spectrometry. , 2011, Analytical biochemistry.

[44]  Alexander Heiss,et al.  Fetuin-A Regulation of Calcified Matrix Metabolism , 2011, Circulation research.

[45]  Huiliang Xie,et al.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. , 2011, Kidney international.

[46]  A. Hayen,et al.  Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. , 2011, JAMA.

[47]  Y. Tintut,et al.  Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. , 2011, Kidney international.

[48]  Á. Millán,et al.  Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. , 2011, American journal of physiology. Cell physiology.

[49]  K. Kalantar-Zadeh,et al.  Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  Takayuki Hamano,et al.  Fetuin-mineral complex reflects extraosseous calcification stress in CKD. , 2010, Journal of the American Society of Nephrology : JASN.

[51]  P. Stenvinkel,et al.  Inflammation in End‐Stage Renal Disease—What Have We Learned in 10 Years? , 2010, Seminars in dialysis.

[52]  J. Powell,et al.  Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. , 2010, Journal of autoimmunity.

[53]  M. Cooper,et al.  Bone loss in inflammatory disorders. , 2009, The Journal of endocrinology.

[54]  N. Fujii,et al.  Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. , 2009, Kidney international.

[55]  R. Villa-Bellosta,et al.  Phosphonoformic Acid Prevents Vascular Smooth Muscle Cell Calcification by Inhibiting Calcium-Phosphate Deposition , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[56]  S. Gordon,et al.  The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges Work in the authors' laboratories is funded by the British Heart Foundation. Published, JLR Papers in Press, December 11, 2008. , 2009, Journal of Lipid Research.

[57]  M. Wolf,et al.  Phosphorus binders and survival on hemodialysis. , 2009, Journal of the American Society of Nephrology : JASN.

[58]  C. Mori,et al.  Transient Increase in Plasma Oxidized LDL During the Progression of Atherosclerosis in Apolipoprotein E Knockout Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[59]  G. Becker,et al.  Small animal models of kidney disease: a review. , 2009, Methods in molecular biology.

[60]  F. Frey,et al.  Sodium thiosulfate prevents vascular calcifications in uremic rats. , 2008, Kidney international.

[61]  Alexandra E. Ewence,et al.  Calcium Phosphate Crystals Induce Cell Death in Human Vascular Smooth Muscle Cells: A Potential Mechanism in Atherosclerotic Plaque Destabilization , 2008, Circulation research.

[62]  W. Richtering,et al.  Hierarchical Role of Fetuin-A and Acidic Serum Proteins in the Formation and Stabilization of Calcium Phosphate Particles* , 2008, Journal of Biological Chemistry.

[63]  T. Eleftheriadis,et al.  The Impact of Chronic Inflammation on Bone Turnover in Hemodialysis Patients , 2008, Renal failure.

[64]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[65]  M. McKee,et al.  Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification , 2008, Journal of Molecular Medicine.

[66]  Timur Shtatland,et al.  Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo , 2007, Circulation.

[67]  James C S Wood,et al.  Characterization of Flow Cytometer Instrument Sensitivity , 2007, Current protocols in cytometry.

[68]  G. H. Nancollas,et al.  Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. , 2006, Bone.

[69]  Jason R. Stubbs,et al.  Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. , 2006, Journal of the American Society of Nephrology : JASN.

[70]  N. Nagano,et al.  Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. , 2006, Kidney international.

[71]  Z. Massy,et al.  Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient Mice , 2005, Circulation.

[72]  J. Skepper,et al.  Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. , 2005, Journal of the American Society of Nephrology : JASN.

[73]  N. Chen,et al.  Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). , 2005, Kidney international.

[74]  B. Kestenbaum,et al.  Serum phosphate levels and mortality risk among people with chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[75]  G. Chertow,et al.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.

[76]  S. Moein Moghimi,et al.  Recognition by Macrophages and Liver Cells of Opsonized Phospholipid Vesicles and Phospholipid Headgroups , 2004, Pharmaceutical Research.

[77]  A. Schwarz,et al.  The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification , 2003 .

[78]  P. Price,et al.  Biochemical Characterization of the Serum Fetuin-Mineral Complex* , 2003, Journal of Biological Chemistry.

[79]  C. Wanner,et al.  Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. , 2003, Kidney international. Supplement.

[80]  T. Renné,et al.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. , 2003, The Journal of biological chemistry.

[81]  C. Wanner,et al.  Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study , 2003, The Lancet.

[82]  P. Price,et al.  Bone Origin of the Serum Complex of Calcium, Phosphate, Fetuin, and Matrix Gla Protein: Biochemical Evidence for the Cancellous Bone‐Remodeling Compartment , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[83]  Will F. Figueira,et al.  Discovery of a High Molecular Weight Complex of Calcium, Phosphate, Fetuin, and Matrix γ-Carboxyglutamic Acid Protein in the Serum of Etidronate-treated Rats* , 2002, The Journal of Biological Chemistry.

[84]  Robert E. Lenkinski,et al.  In vivo near-infrared fluorescence imaging of osteoblastic activity , 2001, Nature Biotechnology.

[85]  N Hussain,et al.  Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. , 2001, Advanced drug delivery reviews.

[86]  K. Tracey,et al.  Fetuin (α2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules , 1998 .

[87]  L. Fernández Cruz,et al.  High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. , 1998, Journal of the American Society of Nephrology : JASN.

[88]  B. Sherry,et al.  Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[89]  W. Jahnen-Dechent,et al.  The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. , 1996, The Journal of biological chemistry.

[90]  J. Seifert,et al.  Rapid insorption of small particles in the gut. , 1990, The American journal of gastroenterology.

[91]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[92]  A. Alfrey,et al.  Renal toxicity of phosphate in rats. , 1980, Kidney international.

[93]  J. Raoult,et al.  Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. , 1979, The Journal of clinical investigation.

[94]  H. Schedl,et al.  Absorption, secretion, and precipitation of calcium in the small intestine of the dog. , 1968, The American journal of physiology.

[95]  I. Gersh.  THE FATE OF COLLOIDAL CALCIUM PHOSPHATE IN THE DOG , 1938 .